Advertisements

Artridol (NSAID)

Quick links to important sections

Artridol (NSAID)

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Artridol (NSAID)

Property Description
Active Ingredients Betamethasone Dipropionate, Indometacin
Form Solution for Injection
Pharmacological Class Glucocorticoid and Nonsteroidal Anti-inflammatory Drug (NSAID) Combination
General Purpose Rapid management of severe inflammation and acute pain
Origin Synthetic (Dual-active formulation)

What Kind of Medicine is Artridol (NSAID)?

Artridol is a synthetic Fixed-Dose Combination (FDC) pharmaceutical product designed for anti-inflammatory and analgesic relief. It is a drug combining a potent Glucocorticoid and a Nonsteroidal Anti-inflammatory Drug (NSAID). This structure reflects its primary purpose: to serve as a comprehensive intervention against severe inflammation and associated pain, a strategy utilized for its effect in acute, high-intensity conditions. Unlike most single-agent products, Artridol provides two distinct pharmacological effects simultaneously. It is typically manufactured as a sterile solution for injection, which is administered either systemically or locally to ensure the rapid bioavailability of the active compounds.


Artridol Composition: A Dual-Action Formulation

The core active ingredients are Betamethasone Dipropionate and Indometacin. Betamethasone Dipropionate is a highly potent corticosteroid ester, known for its ability to broadly suppress inflammatory and immune responses at the second level. Simultaneously, Indometacin is an NSAID that provides targeted pain relief by inhibiting the specific enzymes that contribute to pain and localized inflammation. The synergistic effect of pairing an NSAID with a corticosteroid occurs where their complementary mechanisms deliver a stronger combined therapeutic outcome. This specific composition, featuring a high-potency NSAID and a long-acting corticosteroid ester, differentiates this formulation from combinations utilizing less potent agents.


General Purpose of the Combination Therapy

The overall therapeutic purpose of Artridol is the swift and substantial management of intense inflammatory processes and the related moderate to severe pain, such as acute exacerbations of certain musculoskeletal disorders. This combination strategy is selected because the agents work together to provide superior anti-inflammatory power than either could achieve alone. For patients, the drug offers an option designed to rapidly halt acute inflammatory flare-ups, thereby managing swelling and intense discomfort. The injection form is particularly advantageous for situations requiring an immediate and concentrated effect on the site of inflammation.

Regulatory References

  1. Indomethacin Drug Information (MedlinePlus)
  2. WHO Analgesic Ladder
Advertisements

What side effects are possible with Artridol (NSAID)?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety information for Artridol (NSAID) as presented in government regulatory documents.

Serious and Clinically Significant Risks

Regulatory agencies identify serious risks to key organ systems:

  • Cardiovascular System: Increased risk of serious thrombotic events, including myocardial infarction (heart attack) and stroke. This risk can increase with both higher doses and longer duration of use.
  • Gastrointestinal System: Risk of serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines. This risk is also dose- and duration-dependent.
  • Skin and Hypersensitivity: Rare but severe, potentially fatal skin reactions (such as Stevens-Johnson syndrome) and serious hypersensitivity reactions (anaphylaxis) have been documented.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on their estimated frequency in clinical trials, ranging from Very Common (affecting 1 in 10 users or more) to Very Rare (affecting less than 1 in 10,000 users). System-organ classes commonly involved include:

  • Gastrointestinal Disorders
  • Nervous System Disorders
  • Renal and Urinary Disorders
  • Hepatobiliary Disorders

Safety Restrictions and Limitations

Official labeling contains specific contraindications for use:

  • Third Trimester of Pregnancy: Artridol is prohibited during the last trimester of pregnancy due to documented risks to the developing fetus.
  • Coronary Artery Bypass Graft (CABG) Surgery: The medicine is strictly contraindicated for managing peri-operative pain following CABG surgery.
  • Pre-existing Conditions: Contraindicated in patients with active gastrointestinal bleeding or ulcer, severe heart failure, or severe kidney or liver impairment.

This information reflects how government regulatory documents structure the safety profile by defining major system risks, categorizing likelihoods, and mandating specific use limitations.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Guidance

Overdose information for Artridol, a combination of Indometacin (NSAID) and Betamethasone (Corticosteroid), is defined by the toxicities documented in official regulatory labeling for these two components.

Documented Overdose Manifestations

Symptoms and signs listed in official documents primarily relate to the NSAID component and include:

  • Gastrointestinal Effects: Nausea, Vomiting, Abdominal distress, Diarrhea.
  • Neurological Effects: Severe Headache, Dizziness, Confusion, Extreme tiredness, or Seizures.

Prolonged or excessive systemic exposure to the corticosteroid component may potentially lead to signs of Hyperglycemia or Cushing's syndrome.

Severe Outcomes and Emergency Action

Overdose carries a risk of serious and potentially fatal outcomes, particularly related to the NSAID component. These include the risk of gastrointestinal bleeding, ulceration, or perforation and serious cardiovascular thrombotic events (such as myocardial infarction or stroke).

Immediate medical attention must be sought if an overdose is suspected or if severe symptoms occur. There is no specific antidote documented in official prescribing information for Indometacin overdose.

Management is defined as symptomatic and supportive treatment, which may include close observation and, if appropriate, procedures such as gastric lavage, as determined by clinical judgment.

Population-Specific Overdose Considerations

Regulatory warnings note that the elderly are at greater risk for serious and fatal gastrointestinal events during NSAID exposure. Additionally, pediatric patients may be more susceptible to systemic corticosteroid toxicity, such as HPA axis suppression, with excessive exposure.

Advertisements

Therapeutic Uses of Artridol (NSAID)

The medication is generally applied in clinical settings that involve acute or unstable symptom patterns, relevant when supportive symptomatic management is appropriate.


Therapeutic Focus and Symptom Management

The combination is commonly used across conditions characterized by periods of heightened symptoms that create noticeable physiological strain, primarily within the musculoskeletal domain. It is considered relevant for managing symptoms that become more disruptive during flare-ups, such as those associated with Acute Gouty Arthritis, Ankylosing Spondylitis, and Rheumatoid Arthritis. It is also applied in situations involving moderate to severe osteoarthritis and acute soft tissue inflammation, like acute painful shoulder (bursitis or tendinitis).

“Symptomatic support is often needed during the acute phase when symptoms interfere with daily functioning.”

This therapy helps address symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort such as severe pain, pronounced swelling, and tenderness associated with acute inflammatory or irritative states. It is often used during phases when symptoms become temporarily overwhelming. It contributes to easing the overall symptom load and may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for Inflammatory States The combination is commonly used to help with symptoms related to inflammatory or irritative states and to ease challenging symptoms related to physical discomfort.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Artridol (NSAID)?

The eligibility for the Artridol injection (Indometacin/Betamethasone) is strictly defined by regulatory authorities for its potent dual-active components. Use is generally established for Adults treating specific acute inflammatory musculoskeletal conditions.


Absolute Non-Eligibility (Contraindications)

The medicine is formally prohibited for several patient groups:

  • Patients with a history of allergic reactions to aspirin or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
  • Pregnant women at or after 30 weeks gestation (third trimester) due to documented fetal risks.
  • Patients undergoing peri-operative pain management for Coronary Artery Bypass Graft (CABG) surgery.
  • Patients with severe uncontrolled heart failure or a history of recurrent gastrointestinal ulceration/bleeding.

Restricted or Limited Use

Certain populations require extreme caution and conditional use:

  • Elderly Patients (65+): Use requires greater care and the lowest effective dose due to increased risk of serious adverse events.
  • Patients with Advanced Renal Disease or Severe Hepatic Impairment.
  • The safety and efficacy for the general pediatric population are not established.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Artridol (Indometacin/Betamethasone) documents several interactions, primarily concerning pharmacodynamic risk and drug clearance alteration.

Key Interaction Classes

Category Documented Interaction Constraint
Pharmacodynamic Reinforcement Co-administration with Oral Corticosteroids or other NSAIDs increases the risk of serious gastrointestinal adverse events (e.g., bleeding and ulceration).
Renal Clearance Interference The drug may increase the serum concentration and prolong the half-life of medicines like Digoxin and Lithium, and can increase levels of Methotrexate by decreasing its renal clearance.
Functional Antagonism May diminish the expected antihypertensive effect of ACE Inhibitors, ARBs, or Beta-Blockers, and reduce the natriuretic effect of Diuretics.

Mandatory Restrictions and Specific Notes

Co-administration with Ketorolac is officially contraindicated. Use for peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery is also strictly contraindicated. Risk factors for GI bleeding include concurrent use of alcohol and drugs that interfere with hemostasis (e.g., Warfarin, SSRIs). Regulatory documents note that in elderly or volume-depleted patients, co-administration with ACE Inhibitors or ARBs may result in a greater potential for deterioration of renal function.

Advertisements

Mechanism of Action

Targeting Prostaglandin Synthesis

This domain centers on Artridol's primary action: enzyme-mediated inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This mechanism directly interrupts the conversion of arachidonic acid into prostaglandins, which are key lipid mediators in multiple physiological systems. The resulting physiological effect is a reduction in the local concentration of these signaling molecules.


Influencing Prostanoid-Dependent Pathways

By limiting prostaglandin production, the drug modulates key pathways associated with heightened physiological responses. This early molecular intervention suppresses signaling sequences that would otherwise escalate downstream physiological responses. The outcome is an alteration in the tissue's signaling profile, contributing to an adjustment in downstream cellular processes.


Modulating Peripheral Nociceptor Sensitivity

The mechanistic effect extends to influencing signaling within the microenvironment of peripheral neurons. Reduced levels of prostaglandins modulate nociceptor sensitivity, altering afferent signal transmission to the central nervous system. This action restricts the influence of signaling mediator activity on neuronal function, resulting in downstream physiological adjustments.

Advertisements

Dosage and Administration Information

Directions for Use: Artridol (Naproxen Sodium 220 mg)

Administration involves the use of over-the-counter naproxen sodium (an NSAID), taken via the Oral route with a full glass of water.

Age Group Initial Dose Maintenance Dose Maximum Dose (24h)
Adults and Children (12+ years) 2 caplets (440 mg) within the first hour. 1 caplet (220 mg) every 8 to 12 hours while symptoms last. Do not exceed 3 caplets (660 mg)
Children under 12 years Ask a doctor. Ask a doctor. Ask a doctor.

Procedural and Timing Rules

  • Smallest Effective Dose: Use of the smallest effective dosage for the shortest duration necessary to achieve treatment goals is recommended.
  • Dose Timing: Doses should be spaced at least 8 hours apart. Do not exceed two caplets (440 mg) in any 8- to 12-hour period.
  • Preparation: No preparation steps (e.g., dilution, shaking) are required for the caplet form. Swallow the caplet whole.
  • In Relation to Meals: While not strictly mandated, taking the medication with food or milk may help reduce the chance of stomach upset. Be aware that taking it with food may cause the drug to take longer to work.
  • Missed Dose: If a dose is missed, take it as soon as it is remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for the missed one.
Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies for Artridol (NSAID)


Evidence for Use in Acute Inflammatory Joint Conditions

Research on this dual-active injection was studied for conditions characterized by fluctuating or episodic manifestations, such as Acute Gouty Arthritis and acute Rheumatoid Arthritis flares. Studies examining the component drug classes (NSAIDs and corticosteroids) were often conducted using Randomized Controlled Trials (RCTs). Research explored outcomes related to physical discomfort and objective signs of inflammation like tenderness. For rheumatoid arthritis, trials examined symptom patterns by assessing outcomes reflecting daily functioning or activity level over a defined time interval.

However, specific evidence for the Betamethasone Dipropionate and Indometacin Fixed-Dose Combination (FDC) injection itself is limited, and research is often synthesized from monotherapy trials or comparative studies. In many acute studies, follow-up durations were limited.


Evidence for Use in Chronic and Localized Conditions

Research has also examined the component therapies in scenarios involving fluctuating or unstable symptoms of chronic conditions, including Ankylosing Spondylitis, Moderate to Severe Osteoarthritis, and localized inflammation like Acute Painful Shoulder. Studies monitored outcomes reflecting daily functioning or activity level, as well as patient-reported outcomes describing perceived discomfort. Findings were often reported within research exploring short-term symptom changes rather than long-term functional outcomes.

Comparative evidence is lacking for the specific FDC product against all other common treatments. Furthermore, the evidence quality varies across studies due to differences in research methods and drug doses used.


Long-Term Evidence and Research Gaps

Long-term effects are not fully established for this specific FDC injection, as research was evaluated in scenarios involving episodic or acute changes. The majority of studies focused on studies observing responses over defined time intervals up to several weeks or months. Evidence for the durability of response following the injection is limited.

Data for certain groups, such as older adults or patients with complex comorbidities, remain insufficient within the FDC research context. The primary uncertainty is the lack of high-quality, large-scale RCTs that directly compare the specific FDC injection against all current standard-of-care treatments.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Artridol (NSAID) (FAQ)


Q: Does Artridol help with muscle soreness or only joint pain?

Regulatory documents indicate that Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like those in Artridol are approved for relieving muscular aches and minor pain associated with arthritis, as well as joint conditions. While studies often focus on specific joint conditions, the general anti-inflammatory effect relates to pain from various sources, including muscular aches.


Q: What does 'NSAID' mean in relation to Artridol?

NSAID is an abbreviation for Nonsteroidal Anti-inflammatory Drug. This class of medicine is designed to relieve pain, reduce inflammation, and help lower fever. Artridol contains an NSAID component, often combined with a corticosteroid, to achieve these effects.


Q: Is Artridol something you can take every day for a long time?

Official warnings state the importance of using the smallest effective dose for the shortest possible duration due to the potential risk of serious side effects increasing over time. Studies on the specific combination product have focused on short timeframes, meaning its long-term safety profile is not fully established in research.


Q: Is Artridol considered a first-line treatment for arthritis pain?

Official product information describes Artridol as a potent combination therapy used for the rapid and substantial management of severe inflammation and acute pain. The official description of its role is the rapid management of severe inflammation and acute pain.


Q: What is the difference between Artridol and plain pain relievers?

Artridol is typically a dual-active formulation that combines an NSAID component (for pain and inflammation) with a potent Glucocorticoid (a type of steroid). This composition is defined by its anti-inflammatory and analgesic effects, which is distinct from single-agent pain relievers.


Q: Is it common for people to feel dizzy after taking Artridol?

Dizziness is a side effect that is documented for the components of Artridol and is listed under Nervous System Disorders in official documentation.


Q: Are there any specific activities to avoid while taking Artridol?

Official documentation notes that this medicine may cause drowsiness or dizziness, and this risk applies to activities requiring full mental alertness, such as driving a car or operating machinery. This information is provided to help patients understand potential risks before use.


Q: Is Artridol known to cause fluid retention or swelling?

Official regulatory documents indicate that Artridol's components—both the NSAID and the corticosteroid—may cause fluid retention, or edema. This effect is also noted as a risk factor in patients with pre-existing heart conditions.


Q: Why do some people need a prescription for Artridol?

Regulatory differences exist between the components: Naproxen sodium is widely available over-the-counter (OTC) at lower doses, while the dual-active Indometacin/Betamethasone is typically an injection and requires a prescription due to its higher potency and administration route.


Q: What is the general expectation for pain relief when starting Artridol?

Studies on the NSAID component indicate that pain relief can begin as quickly as 30 minutes, with peak effects generally occurring in one to two hours. However, for inflammatory conditions, the full reduction in symptoms may require a longer duration of use.


Q: What research shows about the effectiveness of Artridol for back pain?

While regulatory studies on the combination product do not explicitly name 'back pain,' the product's approved indications include conditions that are major causes of back pain, such as Ankylosing Spondylitis and Osteoarthritis. The drug's effects on muscular aches and inflammation are also noted.


Q: Does Artridol have any known effects on mental clarity?

Official documentation lists effects on the central nervous system (CNS). In addition to dizziness, higher doses or certain individual sensitivity may lead to symptoms like headache, confusion, or temporary memory problems.


Q: What are the common side effects that usually do not require medical attention?

Patient counseling documents for the components often list less serious side effects, such as mild nausea, heartburn, or headache. These effects are generally expected to be temporary. If they become severe or persist, official advice suggests contacting a healthcare provider.


Q: Is Artridol non-addictive?

Artridol's active ingredients are classified as Nonsteroidal Anti-inflammatory Drugs and Glucocorticoids. These drug classes are not classified as controlled substances and are not associated with the risk of physical dependence or addiction.


Q: What is the typical timeframe for a treatment course of Artridol?

The required timeframe varies based on the condition being treated. For acute issues, treatment may last only a few days. For more chronic issues, it is used 'while symptoms last,' but official guidance stresses the need to keep the duration of use as short as possible.


Q: Can Artridol be used by people with asthma, according to official warnings?

Official warnings indicate that consultation with a healthcare professional is necessary before use if a patient has asthma. This is because NSAIDs can cause a severe allergic reaction, including sudden wheezing or an asthma attack, in sensitive individuals.


Q: What are the signs of a severe allergic reaction to Artridol?

Signs of a serious allergic reaction documented in official warnings include hives, swelling of the face or throat, difficulty breathing or swallowing, hoarseness, and shock. Official warnings emphasize that if these severe signs occur, emergency medical services should be contacted immediately.

Advertisements

How should Artridol (NSAID) be stored and disposed of?

How to Store and Dispose of Artridol (NSAID)?

Official regulatory guidelines strictly define the conditions necessary to maintain the quality and stability of Artridol solution for injection.

Storing Artridol

Condition Requirement (Official Labeling)
Temperature Store at controlled room temperature, typically 20 to 25 C (68 to 77 F).
Protection Must be protected from light and stored away from excess heat and moisture.
Container Keep the container tightly closed and stored in its original outer carton.
Child Safety Keep out of the sight and reach of children in a secure location.

Any solution prepared for administration must be discarded immediately if not used, as the product does not contain a preservative, and is not stable for later use. Exposure to heat sources, such as autoclaving, must be avoided.

Disposal Instructions

Unused, expired, or leftover medicine must be discarded according to local regulations or a take-back program. It is prohibited to release the product to the environment, and the container and contents should be disposed of via an approved pharmaceutical waste procedure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Artridol (NSAID) found in:

A-Z Index: